Question 1

Is oxytocin FDA approved?

Accepted Answer

Yes for one set of uses, no for others. IV and IM oxytocin injection USP is FDA-approved for labor induction, labor augmentation, postpartum hemorrhage control, and milk let-down support. Intranasal oxytocin, subcutaneous oxytocin, and sublingual oxytocin are not FDA-approved as of June 2026. They are investigational or research-use only.

Question 2

How much oxytocin is in 1 IU?

Accepted Answer

Approximately 2 micrograms of pure peptide. That conversion is consistent across labels and PubChem chemistry data. So a 2 mg vial holds roughly 1,000 IU and a 5 mg vial holds roughly 2,500 IU.

Question 3

What is the typical intranasal oxytocin dose used in research?

Accepted Answer

Most human social-cognition trials use somewhere between 10 and 72 IU per session, with 24 IU being the most cited single-session dose since the Kosfeld 2005 Nature trust-game study. The SOARS-B autism trial used up to 48 IU per day split twice daily. These are research-arm doses, not personal recommendations.

Question 4

Does subcutaneous oxytocin work like intranasal oxytocin?

Accepted Answer

Not for central nervous system effects. Subcutaneous oxytocin produces a quick rise in plasma levels but does not cross the blood-brain barrier in meaningful amounts. That is why research targeting brain oxytocin receptors (for example, social cognition) uses the intranasal route rather than subcutaneous.

Question 5

How long does oxytocin last after reconstitution?

Accepted Answer

Reconstituted research-use oxytocin in bacteriostatic water is typically considered usable for about 2-4 weeks when stored at 2-8 degrees Celsius (35.6 to 46.4 degrees Fahrenheit). Discard if it becomes cloudy or develops particulates. Approved injectable oxytocin solutions follow their own FDA-labeled storage instructions.

Question 6

How do I reconstitute a 5 mg oxytocin vial?

Accepted Answer

A common research-lab approach is to add 3.0 mL of bacteriostatic water, which gives about 1.67 mg/mL (roughly 833 IU/mL). On a U-100 insulin syringe, 10 units (0.10 mL) is then about 167 mcg or 83 IU. Use the reconstitution calculator to match BAC water volume to your target dose.

Question 7

Does the largest oxytocin trial in autism show it works?

Accepted Answer

No. The SOARS-B trial (Sikich et al., NEJM 2021), with 290 children and adolescents over 24 weeks, found no significant difference between intranasal oxytocin and placebo on its primary or secondary social and cognitive endpoints. Smaller earlier studies had been more positive, but this larger trial is the strongest evidence to date.

Question 8

Can oxytocin be used for anxiety, depression, or PTSD?

Accepted Answer

There are small human studies suggesting oxytocin may reduce amygdala reactivity or change some anxiety-related measures, but it is not FDA-approved for any psychiatric condition and large trials have generally not supported clinical use. People considering this should talk to a licensed clinician rather than self-administer.

Question 9

What are the most important oxytocin observed effects?

Accepted Answer

For IV obstetric use, the most important effects are uterine hyperstimulation, water intoxication with seizures, and maternal or fetal complications - which is why it is hospital-administered. For intranasal research-context use, observed effects are usually mild (nasal irritation, transient headache, occasional irritability). Subcutaneous research-context use can cause injection-site reactions.

Question 10

Is this page medical advice?

Accepted Answer

No. This is an educational research summary, not personal medical advice. Approved oxytocin (Pitocin) is a hospital drug. Intranasal, subcutaneous, and sublingual oxytocin are investigational or research-use only. Anyone considering oxytocin in any form should talk with a licensed clinician.

Phase	Daily reference amount	Units / volume
Weeks 1–2	100 mcg	6 units (0.06 mL)
Weeks 3–4	200 mcg	12 units (0.12 mL)
Weeks 5–6	300 mcg	18 units (0.18 mL)
Weeks 7–8	400 mcg	24 units (0.24 mL)
Weeks 9–12	500 mcg	30 units (0.30 mL)

Phase	5 mg 3 mL water	10 mg 3 mL water
Weeks 1–2	6 u 0.06 mL	3 u 0.03 mL
Weeks 3–4	12 u 0.12 mL	6 u 0.06 mL
Weeks 5–6	18 u 0.18 mL	9 u 0.09 mL
Weeks 7–8	24 u 0.24 mL	12 u 0.12 mL
Weeks 9–12	30 u 0.30 mL	15 u 0.15 mL

Oxytocin.

Calculated volume reference

Cited protocol & reconstitution guide

Reconstitution by vial size